PharmaCorp Enters Letter of Intent for the Acquisition of Pharmacy Files in Western Canada

Executive Summary

• PharmaCorp Rx Inc. has entered into a non‑binding LOI to acquire prescription files, patient records and related operational data (“Pharmacy Files”) from an arm’s‑length vendor for an anticipated purchase price of $350,000.
• The acquisition will be funded with cash on hand and is expected to close in Q1 2026, subject to execution of a definitive agreement, satisfactory due diligence and customary closing conditions.
• The files will be integrated into PharmaCorp’s existing PharmaChoice‑bannered pharmacy in the same community, enhancing operational efficiency and continuity of patient care.

Key Details

• Target Assets: Prescription files, patient records, and related operational data of a local pharmacy (no corporate entity, fixtures, or other operating assets).
• Purchase Price: Approximately $350,000, subject to customary adjustments; no finder’s fees payable.
• Funding Source: Cash on hand; no external financing required.
• Closing Timeline: Anticipated in the first quarter of 2026, pending definitive agreement and satisfactory due diligence.
• Transaction Structure: Non‑binding LOI → execution of definitive purchase agreement containing customary representations, warranties, indemnities, covenants, and closing conditions.
• Strategic Rationale: Supports PharmaCorp’s national consolidation strategy by adding patient data to an existing pharmacy, improving operational efficiency and patient continuity in the community.
• Quote: “This transaction reflects our disciplined approach to growth and our commitment to strengthening patient care in the communities we serve,” said Alan Simpson, Executive Chair of the Board.

Notable Quotes

“By integrating these Pharmacy Files into our existing pharmacy, we can enhance operational efficiency while ensuring continuity of care for local residents.” – Alan Simpson, Executive Chair, PharmaCorp Rx Inc.